| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (30MB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-520873
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.52087
Zusammenfassung
Oral cancer often presents with aggressive behavior and a high risk of recurrence and metastasis. For oral squamous cell carcinoma (OSCC), which is the most frequent histological subtype, therapy strategies include surgery, radiation therapy, chemotherapy, immune checkpoint inhibitors, and EGFR inhibitors. Recently, a Trop-2 antibody-drug conjugate (ADC) has been approved in the United States of ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik